N Porakishvili

Summary

Affiliation: University of Westminster
Country: UK

Publications

  1. ncbi CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia
    J O Pers
    Institut de Synergie des Sciences et de la Sant, Brest University Medical School, Brest, France
    Leukemia 16:44-52. 2002
  2. ncbi Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes
    N Porakishvili
    Department of Immunology and Molecular Pathology, Royal Free and University College Medical School, London, UK
    Br J Haematol 131:313-9. 2005
  3. ncbi CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells
    Nino Porakishvili
    School of Life Sciences, University of Westminster, London, UK
    Br J Haematol 153:486-98. 2011
  4. ncbi Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)
    N Porakishvili
    Department of Immunology and Molecular Pathology, Royal Free and Middlesex Hospital Medical School, London, UK
    Clin Exp Immunol 126:29-36. 2001

Collaborators

Detail Information

Publications4

  1. ncbi CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia
    J O Pers
    Institut de Synergie des Sciences et de la Sant, Brest University Medical School, Brest, France
    Leukemia 16:44-52. 2002
    ..This heterogeneous apoptotic response to CD5 ligation offers an explanation for the incomplete success of anti-CD5 monoclonal therapy, and might help identify patients who would respond to such treatment...
  2. ncbi Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes
    N Porakishvili
    Department of Immunology and Molecular Pathology, Royal Free and University College Medical School, London, UK
    Br J Haematol 131:313-9. 2005
    ..The differential expression of CD 180 amongst B-CLL patients is one more marker that may define more precisely the different biological properties of this heterogeneous disease...
  3. ncbi CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells
    Nino Porakishvili
    School of Life Sciences, University of Westminster, London, UK
    Br J Haematol 153:486-98. 2011
    ..CD180 may provide powerful expansion and survival signals for Responder B-CLL cells and have an important prognostic value...
  4. ncbi Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)
    N Porakishvili
    Department of Immunology and Molecular Pathology, Royal Free and Middlesex Hospital Medical School, London, UK
    Clin Exp Immunol 126:29-36. 2001
    ....